Improved survival with definitive chemoradiation compared to definitive radiation alone in squamous cell carcinoma of the vulva: A review of the National Cancer Database-Reference-Cited by-同舟云学术

Improved survival with definitive chemoradiation compared to definitive radiation alone in squamous cell carcinoma of the vulva: A review of the National Cancer Database

Published:2017-09 Issue:3 Volume:146 Page:572-579
ISSN:0090-8258
Container-title:Gynecologic Oncology
language:en
Short-container-title:Gynecologic Oncology

Author:

Rao Yuan James,Chin Re-I,Hui Caressa,Mutch David G.,Powell Matthew A.,Schwarz Julie K.,Grigsby Perry W.,Markovina Stephanie

Publisher

Elsevier BV

Subject

Obstetrics and Gynecology,Oncology

Reference27 articles.

1. Cancer statistics, 2017;Siegel;CA Cancer J. Clin.,2017

2. Pelvic exenteration for primary and recurrent vulvar cancer;Miller;Gynecol. Oncol.,1995

3. Exenteration in the treatment of stage III/IV vulvar cancer;Forner;Gynecol. Oncol.,2012

4. Quality of life in women after pelvic exenteration for gynecological malignancies: a Multicentric study;Dessole;Int. J. Gynecol. Cancer,2016

5. Combined therapy as an alternative to exenteration for locally advanced vulvo-vaginal cancer: rationale and results;Boronow;Cancer,1982

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Royal College of Radiologists National Vulvar Cancer Audit;Clinical Oncology;2024-07

2. Basic cell carcinoma of the vulva. Case report and literature review;Obstetrics & Gynecology International Journal;2024-06-04

3. Significance of definitive concurrent chemoradiotherapy for vulvar cancer: a Japanese Gynecologic Oncology Group nationwide survey study;Japanese Journal of Radiology;2024-04-03

4. Upfront boost to gross disease followed by elective pelvic radiation improves compliance to radiation therapy delivery metrics in locally advanced vulvar cancer;Gynecologic Oncology Reports;2024-04

5. Vulvar Cancer, Version 3.2024, NCCN Clinical Practice Guidelines in Oncology;Journal of the National Comprehensive Cancer Network;2024-03